Sensus Healthcare Inc.

NASDAQ: SRTS · Real-Time Price · USD
4.33
0.03 (0.70%)
At close: May 01, 2025, 3:59 PM
4.33
0.00%
After-hours: May 01, 2025, 04:05 PM EDT
0.70%
Bid 4.27
Market Cap 71.43M
Revenue (ttm) 41.81M
Net Income (ttm) 6.65M
EPS (ttm) 0.41
PE Ratio (ttm) 10.56
Forward PE 7.14
Analyst Buy
Ask 4.71
Volume 79,475
Avg. Volume (20D) 260,681
Open 4.29
Previous Close 4.30
Day's Range 4.28 - 4.41
52-Week Range 3.48 - 9.33
Beta 1.11

About SRTS

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and s...

Sector Healthcare
IPO Date Jul 26, 2016
Employees 54
Stock Exchange NASDAQ
Ticker Symbol SRTS
Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for SRTS stock is "Buy." The 12-month stock price forecast is $13, which is an increase of 200.23% from the latest price.

Stock Forecasts

Next Earnings Release

Sensus Healthcare Inc. is scheduled to release its earnings on May 15, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-32.37%
Sensus Healthcare shares are trading lower after t... Unlock content with Pro Subscription
2 months ago
+6.52%
Sensus Healthcare shares are trading lower after the company reported mixed Q4 financial results.